Showing results (1611-1620 of 1,724) with videos related to

Sort By:
Pageof 173
Plos One|June 14, 2022
Evaluating immune response and metabolic related biomarkers pre-allogenic hematopoietic stem cell transplant in acute myeloid leukemiaSharareh Siamakpour-Reihani, Felicia Cao, Jing Lyu, et al.
Frontiers in Pharmacology|August 27, 2019
Combined Blockade of Smad3 and JNK Pathways Ameliorates Progressive Fibrosis in Folic Acid NephropathyMengjie Jiang, Jinjin Fan, Xinli Qu, et al.
Scientific Reports|June 27, 2024
Prevalence, clinical characteristics, and long-term outcomes of new diabetes diagnosis in elderly patients undergoing percutaneous coronary interventionZheng-Kai Xue, Xin-Ya Dai, Jia-Yi Ren, et al.
International Journal of Biological Sciences|June 16, 2023
Induction of Immune Responses and Phosphatidylserine Exposure by TLR9 Activation Results in a Cooperative Antitumor Effect with a Phosphatidylserine-targeting ProdrugJen-Chih Tseng, Jing-Xing Yang, Chia-Yin Lee, et al.
Iscience|August 29, 2022
Randomized controlled trial for time-restricted eating in overweight and obese young adultsLi-Min Zhang, Zhan Liu, Jia-Qi Wang, et al.
Molecular Psychiatry|April 4, 2025
PsycGM: a comprehensive database for associations between gut microbiota and psychiatric disordersDongfang Wang, Siwen Gui, Juncai Pu, et al.
Nanomaterials (Basel, Switzerland)|November 12, 2025
Innovative Application of Nanomaterials in Vegetable Cultivation: Recent Advances in Growth Promotion and Stress ToleranceWenxuan Lv, Yixue Bai, Dongyang Zhu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 29, 2025
Potent Cross-neutralizing Antibodies Reveal Vulnerabilities of Henipavirus Fusion GlycoproteinYi Ren, Pengfei Fan, Xinghai Zhang, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|December 28, 2021
Patterns, treatments, and prognosis of tumor recurrence after resection for hepatocellular carcinoma with microvascular invasion: a multicenter study from ChinaZhen-Hua Chen, Xiu-Ping Zhang, Jin-Kai Feng, et al.
Hepatology International|February 17, 2026
TACE and tyrosine kinase inhibitors with or without PD-1 inhibitors as first-line therapy for intermediate-advanced HCC: a multicenter real-world cohort studyXue-Gang Yang, Li-Wei Deng, Yong Zhao, et al.
Pageof 173